| Univariable analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
Variable | N | HR (95% CI) | p value | HR (95% CI) | p value | |
Age, years | < 65 | 125 | 1 | 0.736 | – | – |
≥65 | 26 | 1.08 (0.69–1.70) |  | – | – | |
Sex | Male | 137 | 1 | 0.806 | – | – |
Female | 14 | 0.93 (0.51–1.69) |  | – | – | |
ECOG PS | 0 | 52 | 1 | 0.158 | – | – |
1–2 | 99 | 1.31 (0.90–1.90) |  | – | – | |
Etiology | HBV | 134 | 1 | 0.403 | – | – |
Non-HBV | 17 | 1.26 (0.73–2.17) |  | – | – | |
Child-Pugh class | A | 140 | 1 | 0.595 | – | – |
B | 11 | 1.20 (0.68–2.38) |  | – | – | |
BCLC stage | B | 5 | 1 | 0.191 | – | – |
C | 146 | 2.15 (0.68–6.76) |  | – | – | |
MVI | No | 88 | 1 | 0.127 | – | – |
Yes | 63 | 1.32 (0.93–1.87) |  | – | – | |
EHS | No | 15 | 1 | 0.090 | – | – |
Yes | 136 | 1.71 (0.92–3.20) |  | – | – | |
AFP (ng/mL) | < 200 | 73 | 1 | 0.008 | 1 | 0.092 |
≥200 | 77 | 1.62 (1.14–2.31) |  | 1.37 (0.95–1.98) |  | |
cfDNA (ng/μL) | ≤0.71a) | 76 | 1 | 0.003 | 1 | 0.245 |
> 0.71a) | 75 | 1.71 (1.20–2.44) |  | 1.27 (0.85–1.88) |  | |
I-score | ≤1637a) | 76 | 1 | < 0.0001 | 1 | 0.011 |
>1637a) | 75 | 2.09 (1.46–3.00) |  | 1.71 (1.13–2.58) |  |